A 76-year-old patient in New Jersey is said to be recovering well after receiving Abiomed Inc.‘s AbioCor artificial heart.
It’s the first commercial implantation since the Danvers cardiac device maker’s artificial heart went through clinical trials and won humanitarian device exemption approval from the Food and Drug Administration in 2006.
The device, which made headlines early this decade as the first self-contined artificial heart, is designed for patient with acute heart failure who don’t qualify for a transplant.